Newron Pharmaceuticals SpA (FRA:NP5) Long-Term Debt : €48.53 Mil (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Long-Term Debt?

Newron Pharmaceuticals SpA's Long-Term Debt for the quarter that ended in Jun. 2024 was €48.53 Mil.

Newron Pharmaceuticals SpA's quarterly Long-Term Debt declined from Jun. 2023 (€34.22 Mil) to Dec. 2023 (€25.75 Mil) but then increased from Dec. 2023 (€25.75 Mil) to Jun. 2024 (€48.53 Mil).

Newron Pharmaceuticals SpA's annual Long-Term Debt increased from Dec. 2021 (€42.54 Mil) to Dec. 2022 (€45.17 Mil) but then declined from Dec. 2022 (€45.17 Mil) to Dec. 2023 (€25.75 Mil).

Newron Pharmaceuticals SpA Long-Term Debt Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Long-Term Debt Chart

Newron Pharmaceuticals SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

16.75

25.67

42.54

45.17

25.75

Newron Pharmaceuticals SpA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Debt	Get a 7-Day Free Trial															43.89	45.17	34.22	25.75	48.53

Newron Pharmaceuticals SpA (FRA:NP5) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Newron Pharmaceuticals SpA Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (FRA:NP5) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

NWPHF:USA 0QOI:UK NP5:Germany NWRN:Switzerland

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Newron Pharmaceuticals SpA Headlines

No Headlines